RadioMedix

RadioMedix

TX - Houston
Pharmaceutical

Focus: Radiopharmaceuticals, Imaging Technology

RadioMedix is a life sciences company focused on Radiopharmaceuticals, Imaging Technology.

OncologyNephrologyNuclear MedicineManufacturing
Funding Stage
PUBLIC
Open Jobs
2

Pipeline & Clinical Trials

N/A
Clinical Trials (1)
NCT0187965768Ga-DOTATATE PET-CT for Diagnosis of Neuroendocrine Tumors (NETs)
N/A
AminoMedixTM for Kidney Protection During Radionuclide Therapy
Radiation Nephropathy
N/A
Clinical Trials (1)
NCT05785663AminoMedixTM for Kidney Protection During Radionuclide Therapy
N/A
Phase 2
Clinical Trials (1)
NCT0228213768Ga-PSMA PET-CT Scan for Diagnosis and Management of Prostate Cancer
Phase 2
Indium-111 pentetreotide
Neuroendocrine Tumors
Phase 2/3
Clinical Trials (1)
NCT00442533Safety and Efficacy Study of In-111 Pentetreotide to Treat Neuroendocrine Tumors
Phase 2/3
Phase 3
Clinical Trials (1)
NCT03673943Imaging of Patients With Known or Suspected Somatostatin Receptor Positive Neuroendocrine Tumors Using Cu64-DOTATATE
Phase 3

Open Jobs (2)

Interview Prep Quick Facts
Portfolio: 5 clinical trials
Open Roles: 2 active jobs